/PRNewswire/ Front Line Medical Technologies Inc, a leader in innovative medical devices for emergency and trauma care, today announced that its innovative.
A new technique used to control severe bleeding in injured patients has been found to increase the risk of death, according to new research from the University of Aberdeen, in Scotland, which was led by University of Alabama at Birmingham trauma surgeon and professor Jan Jansen, Ph.D. Jansen was a surgeon and researcher in Aberdeen before moving to the United States in 2017.
The world’s first clinical trial of Resuscitative Endovascular Balloon Occlusion of the Aorta found that patients treated with REBOA were more likely to die than those who did not undergo REBOA. Written by: Allie Hulcher.
UAB Surgeon Finds No Benefit in New Bleeding Treatment miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.